RQ Bio Announces $115 Million (£85.5 Million) Series A Financing To Advance Long-Acting Antibody Programme RQB01 For Full Season Influenza Prevention

(MENAFN - GlobeNewsWire - Nasdaq) Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph, Wellington Management and founding investor ...